Liraglutide therapy in obese people with type 2 diabetes - Experience of a weight management centre

被引：2

作者：

Elkhenini, Hanaa ^{[1
,2
]}

New, John P.

Summers, Lucinda K. M.

Syed, Akheel A.

机构：

[1] Salford Royal NHS Fdn Trust, Salford M6 8HD, Lancs, England

[2] Univ Teaching Hosp, Salford M6 8HD, Lancs, England

来源：

EUROPEAN JOURNAL OF INTERNAL MEDICINE | 2014年 / 25卷 / 03期

关键词：

Glucagon-like peptide-1 receptor agonists; Obesity; Weight loss;

D O I：

10.1016/j.ejim.2013.12.009

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：E38 / E39

页数：2

共 10 条

[1] Effects of liraglutide in the treatment of obesity: a randomised, double-blind, placebo-controlled study [J].

Astrup, Arne ;

Rossner, Stephan ;

Van Gaal, Luc ;

Rissanen, Aila ;

Niskanen, Leo ;

Al Hakim, Mazin ;

Madsen, Jesper ;

Rasmussen, Mads F. ;

Lean, Michael E. J. .

LANCET, 2009, 374 (9701) :1606-1616

[2] Audit of clinical practice in the use of incretin mimetic agents for the management of patients with type 2 diabetes [J].

Dhesi, Balraj ;

Chauhan, Hiren ;

Basu, Ansu .

PRACTICAL DIABETES, 2013, 30 (04) :159-162

[3] Effects of exenatide in poorly controlled type 2 diabetes* [J].

Kaimal, N. ;

Schofield, J. ;

Zaki, A. ;

Patel, R. ;

Sharma, M. ;

Mccourt, E. ;

Imtiaz, K. E. .

QJM-AN INTERNATIONAL JOURNAL OF MEDICINE, 2012, 105 (04) :321-326

[4] Insights from the Liraglutide Clinical Development Program-the Liraglutide Effect and Action in Diabetes (LEAD) Studies [J].

McGill, Janet B. .

POSTGRADUATE MEDICINE, 2009, 121 (03) :16-25

[5]

NICE, 2010, TECHN APPR TA203 LIR

[6] Liraglutide versus sitagliptin for patients with type 2 diabetes who did not have adequate glycaemic control with metformin: a 26-week, randomised, parallel-group, open-label trial [J].

Pratley, Richard E. ;

Nauck, Michael ;

Bailey, Timothy ;

Montanya, Eduard ;

Cuddihy, Robert ;

Filetti, Sebastiano ;

Thomsen, Anne Bloch ;

Sondergaard, Rie Elvang ;

Davies, Melanie .

LANCET, 2010, 375 (9724) :1447-1456

[7]

Ryder REJ., 2012, HOT TOPICS DIABETES, P49

[8] Dose-dependent improvement in glycemia with once-daily liraglutide without hypoglycemia or weight gain: A double-blind, randomized, controlled trial in Japanese patients with type 2 diabetes [J].

Seino, Y. ;

Rasmussen, M. F. ;

Zdravkovic, M. ;

Kaku, K. .

DIABETES RESEARCH AND CLINICAL PRACTICE, 2008, 81 (02) :161-168

[9] Effects of glucagon-like peptide-1 receptor agonists on weight loss: systematic review and meta-analyses of randomised controlled trials [J].

Vilsboll, Tina ;

Christensen, Mikkel ;

Junker, Anders E. ;

Knop, Filip K. ;

Gluud, Lise Lotte .

BMJ-BRITISH MEDICAL JOURNAL, 2012, 344

[10] What proportion of patients fail NICE criteria for continuing GLP-1 treatment beyond six months, and why? [J].

Wessels, L. ;

Keigan, S. ;

O'Brien, S. V. ;

Hardy, K. J. .

PRACTICAL DIABETES, 2013, 30 (05) :196-198

← 1 →